#NephMadness 2018: 40% Is Good Enough
Navdeep Tangri, MD Dr. Tangri is an Associate Professor in the Department of Medicine at the University of Manitoba. He is interested in the trajectory of patients with [...]
Tangri
Thyroid Testing in Kidney Disease – Should We Be Routinely Assessing?
The decision to screen for subclinical hypothyroidism is controversial, with strong arguments for and against screening and conflicting guidelines from the American [...]
Biomarkers and Thresholds to Identify Bone Turnover: A Retrospective Cohort Study of Bone Biopsies
Bone mineral disease (MBD) is common in patients with chronic kidney disease (CKD), yet remains a diagnostic and therapeutic enigma for clinicians and scientists. In contrast [...]
Providing Dialysis Care During Natural Disasters: Lessons Learnt from Hurricane Sandy
On Oct 29, 2012, Hurricane Sandy made landfall in the United States, and proceeded to affect millions of individuals across multiple states. While natural disasters like [...]
Three Times a Week Dialysis: Is There Evidence for This Dogma?
In an article recently published in AJKD, Kalantar-Zadeh and colleagues present a unique perspective on initiating hemodialysis by questioning the dogma of thrice-weekly [...]
Clinical Trials in Nephrology
Over the last decade, there has been increased recognition that clinical trials in nephrology are fewer in number and smaller in size when compared to other medical [...]
Lifetime Risk of CKD and the Implications for Screening
Chronic kidney disease (CKD) is a common condition with multiple etiologies and important implications. The use of GFR estimation formulas is now ubiquitous in the medical [...]
MesoAmerican Nephropathy: A New Entity
Recently, endemic rates of chronic kidney disease (CKD) have been identified in plantation workers and young farmers in Central America. The clinical profile of these [...]
Hyponatremia and the Risk of Death on Dialysis
In a recent article published in the American Journal of Kidney Diseases, Nigwekar et al examined data from an incident dialysis patient cohort (ArMORR) and concluded that [...]